Department of Forensic Toxicology, Institute of Legal Medicine, University Hospital Münster, Röntgenstr, 23, 48149, Münster, Germany.
Organisch-Chemisches Institut, Westfälische Wilhelms-Universität Münster, Corrensstrasse 40, 48149, Münster, Germany.
Int J Legal Med. 2020 Nov;134(6):2105-2119. doi: 10.1007/s00414-020-02387-w. Epub 2020 Aug 17.
(-)-Δ-9-tetrahydrocannabinol ((-)-Δ-9-THC) is the main psychoactive constituent in cannabis. During phase I metabolism, it is metabolized to (-)-11-hydroxy-Δ-9-tetrahydrocannabinol ((-)-11-OH-Δ-9-THC), which is psychoactive, and to (-)-11-nor-9-carboxy-Δ-9-tetrahydrocannabinol ((-)-Δ-9-THC-COOH), which is psychoinactive. It is glucuronidated during phase II metabolism. The biotransformation of (-)-Δ-9-tetrahydrocannabinol-glucuronide ((-)-Δ-9-THC-Glc) and (-)-11-nor-9-carboxy-Δ-9-tetrahydrocannabinol-glucuronide ((-)-Δ-9-THC-COOH-Glc) is well understood, which is mainly due to the availability of commercial reference standards. Since such a standardized reference is not yet available for (-)-11-hydroxy-Δ-9-tetrahydrocannabinol-glucuronide ((-)-11-OH-Δ-9-THC-Glc), its biotransformation is harder to study and the nature of the glucuronide bonding-alcoholic and/or phenolic-remains unclear. Consequently, the aim of this study was to investigate the biotransformation of (-)-11-OH-Δ-9-THC-Glc in vitro as well as in vivo and to identify the glucuronide by chemically synthesis of a reference standard. For in vitro analysis, pooled human S9 liver fraction was incubated with (-)-Δ-9-THC. Resulting metabolites were detected by high-performance liquid chromatography system coupled to a high-resolution mass spectrometer (HPLC-HRMS) with heated electrospray ionization (HESI) in positive and negative full scan mode. Five different chromatographic peaks of OH-Δ-9-THC-Glc have been detected in HESI positive and negative mode, respectively. The experiment set up according to Wen et al. indicates the two main metabolites being an alcoholic and a phenolic glucuronide metabolite. In vivo analysis of urine (n = 10) and serum (n = 10) samples from cannabis users confirmed these two main metabolites. Thus, OH-Δ-9-THC is glucuronidated at either the phenolic or the alcoholic hydroxy group. A double glucuronidation was not observed. The alcoholic (-)-11-OH-Δ-9-THC-Glc was successfully chemically synthesized and identified the main alcoholic glucuronide in vitro and in vivo. (-)-11-OH-Δ-9-THC-Glc is the first reference standard for direct identification and quantification. This enables future research to answer the question whether phenolic or alcoholic glucuronidation forms the predominant way of metabolism.
(-)-Δ-9-四氢大麻酚((-)-Δ-9-THC)是大麻中的主要精神活性成分。在 I 期代谢过程中,它被代谢为(-)-11-羟基-Δ-9-四氢大麻酚((-)-11-OH-Δ-9-THC),这是具有精神活性的,和(-)-11-去甲-9-羧酸-Δ-9-四氢大麻酚((-)-Δ-9-THC-COOH),这是精神无活性的。在 II 期代谢过程中,它被葡糖醛酸化。(-)-Δ-9-四氢大麻酚葡糖苷酸((-)-Δ-9-THC-Glc)和(-)-11-去甲-9-羧酸-Δ-9-四氢大麻酚葡糖苷酸((-)-Δ-9-THC-COOH-Glc)的生物转化过程已得到很好的理解,这主要是因为有商业参考标准的可用性。由于(-)-11-羟基-Δ-9-四氢大麻酚葡糖苷酸((-)-11-OH-Δ-9-THC-Glc)尚未有标准化的参考标准,因此其生物转化更难研究,葡糖苷键的性质(醇性和/或酚性)仍不清楚。因此,本研究的目的是在体外和体内研究(-)-11-OH-Δ-9-THC-Glc 的生物转化,并通过化学合成参考标准来鉴定葡糖苷酸。对于体外分析,将人 S9 肝部分的混合物与(-)-Δ-9-THC 一起孵育。通过高效液相色谱系统与加热电喷雾电离(HESI)在正、负全扫描模式下耦合高分辨率质谱(HPLC-HRMS)检测到代谢产物。在 HESI 正、负模式下分别检测到五个不同的 OH-Δ-9-THC-Glc 色谱峰。根据 Wen 等人的实验设置,表明两种主要代谢产物是醇性和酚性葡糖苷酸代谢产物。对来自大麻使用者的尿液(n=10)和血清(n=10)样本的体内分析证实了这两种主要代谢产物。因此,OH-Δ-9-THC 在酚或醇羟基处被葡糖醛酸化。未观察到双葡糖苷酸化。醇性(-)-11-OH-Δ-9-THC-Glc 已成功地通过化学合成并在体外和体内鉴定出主要的醇性葡糖苷酸。(-)-11-OH-Δ-9-THC-Glc 是直接鉴定和定量的第一个参考标准。这使得未来的研究能够回答酚性或醇性葡糖苷酸化是主要代谢途径的问题。